Analgil

Quick links to important sections

Analgil

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Analgil

Property Description
Active ingredient Methyl Salicylate (INN)
Form Topical preparation (e.g., Liniment, Cream, Ointment)
Pharmacological class Topical Analgesic, Counterirritant
Common use Localized relief of minor muscle and joint discomfort
Origin Synthetic chemical ester (related to oil of wintergreen)

What Type of Medicine is Analgil (Methyl Salicylate)?

Analgil, containing the active component Methyl Salicylate, is classified as a topical analgesic and rubefacient intended exclusively for external cutaneous application. This medication belongs to the salicylate pharmacological class and is typically available as an over-the-counter (OTC) product. This medicine is clinically recognized for providing effective relief through localized action, often positioned for patients seeking to ease discomfort such as muscle stiffness and general minor pain following physical exertion. This approach contrasts with oral analgesics, as Analgil's core strategy involves generating a mild, focused sensation on the skin, which helps to distract from underlying discomfort signals.

Composition and Physical Form of Analgil

The essential active ingredient is Methyl Salicylate, a chemical ester of salicylic acid. While this compound is naturally sourced as oil of wintergreen, the pharmaceutical-grade substance utilized in Analgil is commonly produced synthetically to guarantee consistent purity and strength. Analgil is compounded into various topical preparations, frequently offered as a soothing, non-greasy liniment or cream. These formulations utilize an appropriate vehicle base, such as an oleaginous or emulsion base, to ensure the active compound is efficiently held and locally absorbed through the skin. These salicylate esters are known for their ability to be locally absorbed to exert their primary action.

What side effects are possible with Analgil?

Possible side effects and safety information

The safety profile of Analgil (Topical Methyl Salicylate) is officially defined by both local application-site reactions and potential systemic risks associated with the absorption of the salicylate component, which is classified as an NSAID in regulatory contexts. The majority of documented adverse reactions are dermatological, involving the skin and subcutaneous tissue.

The most frequently encountered effects documented in regulatory labeling are related to the local action of the preparation, including mild skin irritation, redness, burning or stinging sensations, and dryness at the application site. For many of these local effects, a definitive frequency classification is often labeled as Incidence not known in official documents.

The safety profile also includes documentation of serious adverse reactions, though these are rare. These include severe chemical burns (second- or third-degree), which have been documented in rare cases, sometimes occurring within 24 hours of first application. Due to systemic absorption, the potential for major cardiovascular (CV) thrombotic events (such as myocardial infarction or stroke) and serious gastrointestinal (GI) events (such as bleeding or ulceration) is included in the high-level safety constraints, with the risk of CV events potentially increasing with the duration of use.

Specific population and usage limitations are detailed in official labeling. The medication is contraindicated in individuals with known Aspirin or NSAID-related allergies or immediately before or after Coronary Artery Bypass Graft (CABG) surgery. Additionally, official documents advise against use during the last 3 months of pregnancy. Older adults (age 60 or older) have a documented increased risk for serious GI events.

Overdose and Emergency Response

Overdose of Analgil (Methyl Salicylate topical) is officially defined by the risk of Systemic Salicylate Toxicity following accidental ingestion or the application of excessive amounts to large areas of the skin. The severity of overdose is classified based on the progression of these systemic effects.

Documented Overdose Manifestations:

  • Gastrointestinal Distress: Vomiting, abdominal pain, and nausea are listed in regulatory sources.
  • Neurological/Systemic Effects: Tinnitus (ringing in the ears), headache, dizziness, confusion, and sustained hyperventilation are commonly documented signs of systemic absorption.
  • Severe Outcomes: The official profile lists life-threatening complications, including seizures, progression to coma, respiratory failure, and profound metabolic acidosis.

When to Seek Urgent Help:

  • The official label strictly mandates that if the product is swallowed or if systemic symptoms occur, an individual must seek medical help or contact a Poison Control Center right away.
  • Immediate Emergency Services (e.g., call 911) are required if the affected person collapses, has a seizure, or experiences severe difficulty breathing.

Management and Population Notes:

  • Overdose management officially involves symptomatic and supportive measures, including the use of activated charcoal and advanced procedures like hemodialysis for severe toxicity.
  • Regulatory information notes that children are particularly sensitive to these systemic effects, and individuals with impaired renal or hepatic function are at a higher risk.

Therapeutic Uses of Analgil

Analgil is commonly used in situations involving certain distressing symptoms related to physical discomfort in muscles and joints. It is generally applied when short-term symptomatic assistance is needed for minor aches and pains. It is commonly used to help with symptoms associated with muscle strains, sprains, simple backache, and localized joint aches.

Symptomatic Domains and Patient Benefit

Analgil is commonly used across conditions presenting with acute episodes of localized discomfort and stiffness in soft tissues. It provides support that helps ease the overall symptom burden, helping address symptom clusters that may become intense or disruptive. This preparation is relevant in conditions characterized by periods of heightened symptoms of mild to moderate pain, and may assist with maintaining functional stability by contributing to improved comfort during periods of heightened symptoms. The medication is also helpful in situations requiring additional symptomatic assistance for the soreness and physical strain that commonly follow demanding physical exertion.

“The supportive relief offered may help patients cope more steadily with temporary discomfort and assist with maintaining functional stability.”

Quick Fact: Relief for Localized Aches
Symptom Focus: Minor muscle soreness, stiffness, and joint aches.
Typical Context: Post-exertion recovery and temporary flare-ups of discomfort.
Core Benefit: Provides support that helps ease the overall symptom burden.

Regulatory References

  1. NIH DailyMed Labeling for Methyl Salicylate

Eligibility and Restrictions for Use

The official regulatory documents for Analgil (Methyl Salicylate topical) define eligibility based on specific physiological states, age, and existing medical conditions, primarily due to its classification as a salicylate-containing product. All eligibility criteria are strictly based on government-approved labeling.

Population Status Eligibility Rule
Contraindicated Populations Use is strictly prohibited for individuals with a known allergy or hypersensitivity to Methyl Salicylate, aspirin, or other Non-Steroidal Anti-inflammatory Drugs (NSAIDs). The medicine is also contraindicated right before or after heart bypass surgery and must not be applied to wounds or damaged skin or rashes.
Pregnancy and Lactation Use is absolutely prohibited during the last three months of pregnancy due to regulatory concerns. For the first six months of pregnancy and while breastfeeding, consultation with a health professional is mandatory before use.
Age-Related Rules Safety and efficacy have not been established for children under 12 years of age. Use is specifically restricted in children and teenagers with viral illnesses (such as the flu or chickenpox) due to the recognized risk of Reye's syndrome. Older adults age 60 and above should proceed with caution due to documented increased risk.
Comorbidity Limitations Individuals must consult a health professional before use if they have specific underlying medical conditions, including a history of stomach ulcers, bleeding problems, high blood pressure, heart disease, or kidney disease.

What should I know about interactions with other medicines?

The drug, whose active ingredient is metamizole, has officially documented drug-drug interactions that are classified based on the resulting clinical requirements, including necessary therapeutic monitoring and avoidance of certain combinations.

Key Interaction Categories

Interacting Product Category Practical Regulatory Implication
Immunosuppressants (e.g., Cyclosporine) Requires therapeutic drug monitoring (TDM) and dosage adjustment due to a risk of reduced plasma concentrations of the co-administered drug.
CYP3A4 and CYP2B6 Substrates (e.g., Bupropion, Efavirenz, Methadone) May lead to decreased plasma concentrations of these medicines because the drug is a moderate-to-strong enzyme inducer, necessitating a dose increase or alternative therapy.
Anticoagulants/Antiplatelets (e.g., Acetylsalicylic acid) Combination with low-dose acetylsalicylic acid may inhibit its cardioprotective antiplatelet effect, requiring careful consideration of the sequence and timing of administration.
Antihypertensives (e.g., beta-blockers, ACE inhibitors) May diminish the effects of certain agents, requiring blood pressure monitoring to confirm therapeutic efficacy.
Methotrexate Co-administration may increase the risk of Methotrexate toxicity due to reduced clearance, especially with higher dosages of this drug.

These interactions establish constraints on co-administration, requiring healthcare providers to consider alternative pain relief, monitor drug levels, or adjust the dosage of the interacting medicine to maintain its efficacy and safety profile.

Mechanism of Action

Analgil exerts its action through the pharmacodynamic modulation of specific biological systems, focusing on the regulation of key signaling pathways and molecular processes within target tissues.

Modulation of Receptor-Mediated Signaling

The mechanism involves Analgil's action on specific cell-surface or intracellular receptors. Upon binding, the drug initiates or inhibits cellular responses, thereby engaging mechanisms that regulate signaling sequences mediated by these receptors, which results in downstream physiological alterations.

Targeted Enzyme-Inhibition Cascades

Analgil modulates enzymatic activity through direct inhibition or activation of specific enzymes. This molecular interaction alters the rate of mediator production, thereby suppressing signaling sequences and inducing a change in feedback regulation within targeted pathways.

Regulation of Neurotransmitter/Mediator Release

The final domain affects systems where specific transmitters or inflammatory mediators dominate. By influencing the mechanisms of release, reuptake, or synthesis of these molecules, Analgil modifies signaling sequences, ultimately leading to reduced pathway activation and a decrease in the concentration or effect of specific mediators in the microenvironment.

Dosage and Administration Information

How to Use Analgil (Methyl Salicylate)

The administration of Analgil is characterized by certain parameters that describe its usage. This information describes the standardized application parameters without offering clinical advice.


Administration Scope and Method

The route for Analgil, containing Methyl Salicylate, is strictly topical for external, cutaneous application only. The typical regimen requires applying an amount that forms a thin layer over the affected area, where the dose is functional and determined by coverage rather than a fixed volumetric measurement. The preparation must be gently and completely massaged into the skin until absorbed, and administration is specified for application to unbroken skin only.


Frequency and Duration Protocols

Analgil application is limited to a maximum of three to four times per day (TID or QID), reflecting an as-needed use pattern. The medicine is designated for short-term, intermittent use. Continuous application must not exceed 7 days; use beyond this period requires professional consultation to ensure continued appropriateness.


Procedural Constraints

Specific rules govern the administration environment. Treated areas must not be subjected to external heat, such as heating pads, and the application site must not be bandaged tightly or covered with occlusive materials. For age-based rules, the use of Analgil is restricted in children under 12 years of age unless explicitly directed by a healthcare professional. Should an application be missed, the regimen continues without applying extra amounts, as the total frequency must still not exceed the four times daily limit.

These details establish a clear, standardized application protocol that describes the administration of the topical preparation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Analgil (Topical Methyl Salicylate)


Evidence for Use in Acute Muscle and Joint Discomfort

Research has examined Analgil in the context of temporary, minor muscle strains and soft tissue aches, primarily involving short-term randomized controlled trials (RCTs). These RCTs are typically designed to be double-blind and placebo-controlled.

These studies mainly focused on measuring changes in outcomes related to physical discomfort over short periods, often between 8 and 12 hours after topical application, with total observation periods usually lasting up to 7 days. Findings describe patterns observed in the studies, where researchers measured reported outcomes related to physical discomfort compared to the start of the study. When these individual studies are aggregated, the evidence contributes to understanding symptom patterns, but the overall certainty is often described as low by scientific reviews, due to varying results and study quality.


Evidence for Use in Chronic Joint Conditions

Research has also examined Analgil in the context of conditions associated with more persistent discomfort, such as chronic joint pain or localized osteoarthritis. These studies include RCTs designed for slightly longer observation periods.

The Study Landscape and Consistency of Findings

Placebo and Comparator Research in Trials

Research examined how Analgil performed when compared directly to an inactive preparation (placebo). The outcomes related to physical discomfort were typically tracked using patient-reported outcomes describing perceived discomfort. However, the use of co-formulations is a limitation cited in the research that may make it challenging for researchers to isolate the specific patterns related only to the methyl salicylate component.


Long-Term Data and Extended Follow-up

Research focusing on extended follow-up durations for Analgil is limited. The typical follow-up durations in the main clinical trials were short, focusing on episodic or acute changes in symptoms. Consequently, long-term effects are not fully established regarding what happens when Analgil is used regularly over many months or years. Researchers note that there is limited information for long-term outcomes and safety, which may result in the evidence being categorized as having low certainty for extended use.

Key Studies & References NIH DailyMed Labeling for Methyl Salicylate Topical Preparations

Frequently Asked Questions (FAQ)

Common questions about Analgil (FAQ)


Q: What is the main difference between Analgil and over-the-counter pain relievers?

Official product information describes Analgil as a topical preparation applied to the skin, which means it provides localized relief for minor muscle and joint discomfort. This approach contrasts with most oral over-the-counter pain relievers, which are absorbed systemically (throughout the entire body) to take effect.


Q: Can Analgil be taken for headaches or is it only for severe pain?

The regulatory indications limit the use of Analgil to the temporary, local relief of minor aches and pains in muscles and joints due to conditions like sprains or bruises. It is not approved for the treatment of internal pain, such as headaches, or for severe pain.


Q: Can Analgil interact with common cold or flu medications?

Regulatory documents warn against using this product with any other medications that contain NSAIDs (non-steroidal anti-inflammatory drugs) or aspirin. Since certain cold or flu medications may include these ingredients, official information recommends checking the ingredient list to confirm compliance with regulatory warnings.


Q: Is Analgil effective for chronic nerve pain?

While the primary indication is for muscle and joint discomfort, some authoritative sources have referenced the temporary relief of nerve pain in discussions regarding the product’s uses.


Q: How does Analgil compare to NSAIDs like ibuprofen, regarding side effects?

Because Analgil is applied topically, the most common side effects are local skin reactions like irritation, redness, or a burning sensation. Regulatory documents note that the product carries the official warnings for serious cardiovascular and gastrointestinal risks associated with the NSAID class.


Q: What should I do if I suspect an interaction between Analgil and another medicine?

Official documents advise that stopping use and consulting with a doctor or health professional is necessary if an interaction is suspected between Analgil and any other medicine you are using.


Q: Is Analgil the same drug as [common drug name] under a different brand?

Analgil is a brand name. The active ingredient it contains is Methyl Salicylate, which is the official generic name for the compound. This generic ingredient is found in many other branded and generic topical pain relief products.


Q: Is there a specific maximum daily dose mentioned in the prescribing information?

Official regulatory labeling defines the maximum use by frequency, generally not more than three to four times in a single day. The amount to apply is defined by coverage—a thin layer over the affected area—rather than by a fixed volumetric measurement.


Q: What should I do if I experience a severe side effect from Analgil?

Regulatory guidelines direct users to stop using the product immediately and seek medical help if any severe adverse reaction is experienced. This includes signs of serious internal bleeding, such as bloody stools or vomiting blood, or severe skin reactions like blistering.


Q: How quickly can I expect Analgil to start working?

Official product information indicates that some individuals may not experience pain relief until several hours after applying the product. Clinical studies have typically observed outcomes within an 8- to 12-hour period following a single application.


Q: How long does the effect of Analgil usually last?

Clinical trials that support the regulatory information have typically assessed the duration of pain relief for up to 8 to 12 hours following a single application.


Q: Does Analgil cause drowsiness or make it difficult to drive?

The official product labeling does not list drowsiness or impaired driving ability as a standard, expected side effect of proper use. However, regulatory documents state that high levels of systemic absorption (toxicity) can lead to central nervous system effects such as lethargy and confusion.


Q: Is it normal to feel a bit nauseous after taking Analgil?

Nausea and vomiting are not typical side effects of routine, proper topical use. These symptoms are listed in regulatory documents as potential signs of salicylate poisoning, which is a rare form of systemic toxicity from excessive absorption or accidental ingestion.


Q: Are there any specific foods or drinks I need to avoid while on Analgil?

There are no specific food interactions listed in regulatory documents. However, official warnings caution against consuming three or more alcoholic drinks daily while using this product because this can increase the risk of stomach bleeding.


Q: Why is Analgil sometimes prescribed for conditions other than pain?

Analgil is only officially indicated for the temporary relief of minor aches and pains of muscles and joints due to arthritis, simple backache, sprains, and bruises.


Q: Does Analgil show up on standard drug screening tests?

The active ingredient, Methyl Salicylate, is absorbed through the skin and metabolized into Salicylic Acid. Due to this systemic presence, the active ingredient may potentially result in a positive finding on a standard salicylate screening test.


Q: What is the risk of liver problems associated with Analgil use?

Liver problems are not listed as a routine side effect for proper use. However, severe systemic toxicity from excessive use or accidental ingestion has been documented to interfere with liver and metabolic functions.


Q: Do the side effects of Analgil typically go away after a few days?

Official information states that the minor burning sensation or irritation that may occur upon application usually subsides after a few days of using the medication regularly.


Q: What happens if Analgil stops working for me?

Regulatory instructions advise that stopping use and consulting a doctor is necessary if pain does not improve after 7 days of use, or if symptoms get worse or recur.


Q: Does Analgil have any warnings related to driving heavy machinery?

Official labeling does not typically include an explicit warning regarding the use of heavy machinery. The only potential concern is that severe systemic toxicity from excessive use can result in confusion and lethargy, which would impair activities like driving.


Q: Why are there warnings about Analgil and alcohol consumption?

The warning about alcohol consumption is due to the product containing an NSAID. This is because consuming three or more alcoholic drinks daily while using the product may significantly increase the risk of stomach bleeding.


Q: Does Analgil carry a 'Black Box' warning from the FDA?

Official labels contain major warnings regarding the potential for serious cardiovascular and gastrointestinal events, which are the risks associated with the highest-level regulatory warnings given to NSAID products.


Q: What should I tell my dentist before a procedure if I am taking Analgil?

Regulatory safety warnings related to bleeding risk suggest that informing your dentist or surgeon about all medications used before any procedure is a necessary caution.


Q: Does taking Analgil affect the results of blood tests?

Since the active ingredient is absorbed through the skin into the bloodstream, it is metabolized into salicylic acid. This systemic presence means that it can potentially affect blood tests that specifically screen for salicylate levels.


Q: Are there any specific vision or eye-related side effects linked to Analgil?

Official instructions warn patients to avoid getting the product in the eyes, mouth, or mucous membranes and to rinse thoroughly with water if contact occurs. No specific vision-related side effects are listed for use as directed.

How should Analgil be stored and disposed of?

How to Store and Dispose of Analgil

Official regulatory guidelines for Analgil (Methyl Salicylate topical) mandate storage at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must not freeze and should be protected from excessive heat and moisture. To maintain integrity, the container must be kept tightly closed and stored in its original packaging.


Child Safety and Disposal

It is officially required to keep the medicine out of reach of children.

To dispose of unused or expired Analgil, follow established regulatory procedures. Do not pour the product down the drain or flush it. The preferred method for discarding the medicine is through an authorized drug take-back program. If no take-back program is available, mix the product with an undesirable substance, seal it in a container, and place it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Analgil found in:

A-Z Index: